[Porphyria cutanea tarda and HCV infection]

Area of Science:

• Hepatology
• Metabolic Disorders
• Infectious Diseases

Background:

• Porphyria cutanea tarda (PCT) is the most prevalent disorder affecting heme biosynthesis.
• PCT is frequently associated with underlying liver dysfunction.
• Hepatitis C virus (HCV) infection is a known comorbidity impacting liver health.

Observation:

• Three cases of patients with co-occurring PCT and HCV infection were treated at the Department of Infectious Diseases.
• The study observed the progression from initial metabolic derangements to definitive diagnosis in these patients.
• Clinical observations focused on the manifestation of PCT symptoms in the context of HCV infection.

Findings:

• The study illustrates the diagnostic pathway for patients presenting with both PCT and HCV infection.
• Treatment interventions were administered, and their influence on the disease course was monitored.
• Successful management strategies were identified for this specific patient cohort.

Implications:

• Understanding the interplay between PCT and HCV infection is crucial for effective patient management.
• This case series provides insights into the diagnostic and therapeutic challenges in co-infected patients.
• The findings contribute to the broader knowledge of metabolic disorders and viral hepatitis co-infections.